logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
I

Izmir Economy University Medical Point Hospital

Scholars2
Papers2
Citations0
Related Papers (2)
Publication Date
delete
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
errThe Lancet Respiratory Medicine
IF0
err2025-09-19
err0
PREAI
errShun Lu; Oleksandr Vynnychenko; Yaroslav Kulyaba; Vladimer Kuchava; Aishah Ibrahim; Fedor Moiseenko; Cagatay Arslan; Duong Thanh Nguyen; Marina Petrovic; Irfan Cicin; Khatuna Bibichadze; Timucin Cil; Jianhua Shi; Omer Fatih Olmez; Miranda Gogishvili; Mehmet Artac; Hoang Gia Nguyen; Mark Cornfeld; Chuan Tian; Mihaela C Munteanu; Claudia V M Sette; Igor Bondarenko
errShare
errSave